DB95.7

ICD-11 MMS 2026-01

Drug-induced or toxic liver disease with liver tumours

Description

Medication and chemical exposure have been associated with many forms of hepatic neoplasms, including focal nodular hyperplasia, hepatic adenoma, hepatocellular carcinoma, cholangiocarcinoma and angiosarcoma.

Index terms

  • Drug-induced or toxic liver disease with liver tumours

Exclusions from above levels

  • DB94 – Alcoholic liver disease
  • DB98.5 – Budd-Chiari syndrome
  • ME10.1 – Unspecified jaundice
Show allHide
  • 01 – Certain infectious or parasitic diseases
  • 02 – Neoplasms
  • 05 – Endocrine, nutritional or metabolic diseases
  • 06 – Mental, behavioural or neurodevelopmental disorders
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • DB95.0 – Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis
  • DB95.1 – Drug-induced or toxic liver disease with chronic hepatitis
  • DB95.2 – Drug-induced or toxic liver disease with cholestasis
  • DB95.3 – Drug-induced or toxic liver disease with fatty liver
  • DB95.4 – Drug-induced or toxic liver disease with granulomatous hepatitis
  • DB95.5 – Drug-induced or toxic liver disease with fibrosis or cirrhosis of liver
  • DB95.6 – Drug-induced or toxic liver disease with vascular disorders of the liver
  • DB95.Y – Other specified drug-induced or toxic liver disease
  • DB95.Z – Drug-induced or toxic liver disease, unspecified

Foundation entity

Drug-induced or toxic liver disease with liver tumours – http://id.who.int/icd/entity/593696296

Allowed postcoordination axes

Part of: DB95: Drug-induced or toxic liver disease › 13: Diseases of the digestive system